March 14, 2023 announcement:Novo Nordisk announced that it would reduce the wholesale list prices for several types of insulin, effective Jan. 1, 2024. This includes:
- Reducing the list price of NovoLog®and NovoLog®Mix 70/30 by 75% off the current list price.
- Reducing the list price of Novolin®and Levemir®by 65% off the current list price.
- The list price of the unbranded insulins (pre-filled pens and vials and pre-mix insulins) to match the lowered price of each respective branded insulin.
The ADA is gathering more information about what the experience will be for consumers beginning in 2024 and will provide more details as they become available.
Patient Assistance Program (PAP):This program has been enhanced to provide insulin free of charge for 90 days to eligible participants. Effective April 1, 2020, Medicare patients were no longer required to pay $1,000 for medicines before being eligible for the Novo Nordisk PAP. To be eligible, a person must:
- Be a U.S. citizen or legal resident.
- Have a total household income at or below 400% of the federal poverty level (FPL). See NeedyMeds for a list of the current FPL guidelines. A family of four with an annual income up to $104,800 may receive free medications through Novo Nordisk's PAP. For individuals, the annual income limit for participation is $51,040.
- Be uninsured, or in the Medicare program.
- Not be enrolled in or qualify for any other federal, state or government program such as Medicaid, Low Income Subsidy, or Veterans (VA) Benefits.
- Exceptions include patients who are Medicaid eligible who have applied for and been denied Medicaid.
My$99Insulin:For $99, people with diabetes can get up to three vials or two packs of FlexPen®/FlexTouch®/PenFill® pens, of any combination of Novo Nordisk Inc. insulins with a prescription.
Follow-on brand (also known as authorized generics) insulins: Follow-on brand versions of NovoLog® and NovoLog® Mix, from Novo Nordisk Pharma, Inc. (NNPI), a Novo Nordisk A/S US company, can be ordered at one's local pharmacy, and cost 50 percent off the current list prices of the branded medicines.
Immediate Supply: A short-term, immediate-need program for those at risk of rationing while working to identify a longer-term solution. Novo Nordisk may be able to help by providing a free, one-time, immediate supply of up to three vials or two packs of pens of Novo Nordisk Inc. insulin with a prescription.
Novo Nordisk human insulin, named ReliOn™, available at Walmart for about $25/vial and for about $44/box of FlexPen®. Similar offerings are found at CVS and other national pharmacies.
Copay Savings Cards to help defray the costs for commercially insured patients who are experiencing high out-of-pocket costs. If you have insurance through your employer or private insurance, you may pay as little as $5 per 30-day supply of Tresiba® (maximum savings of $150 per 30-day supply) and/or $25 per 30-day supply of Novolog® (maximum savings up to $100 per 30-day supply) for up to 24 months.
For more informationabout Novo Nordisk insulins and affordability programs visitMyNovoInsulin.com.
